Literature DB >> 22545289

Tumour immunotherapy--leukocytes take up the fight.

Gemma K Alderton, Yvonne Bordon.   

Abstract

The immune system can promote the elimination of tumours, but often immune responses are modulated or suppressed by the tumour microenvironment. In this joint Focus from Nature Reviews Cancer and Nature Reviews Immunology, leading researchers describe our current understanding of the complex interactions that occur between the immune system and tumour cells, and discuss how the power of the immune system can be harnessed by anticancer immunotherapies.

Entities:  

Mesh：

Year:  2012        PMID： 22545289     DOI： 10.1038/nri3197

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


  10 in total

Review 1.  Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.

Authors:  Rafael Tabarés-Seisdedos; John L Rubenstein
Journal:  Nat Rev Neurosci       Date:  2013-04       Impact factor: 34.870

2.  Targeting immunosuppression for cancer therapy.

Authors:  Cristina Ghirelli; Thorsten Hagemann
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

3.  killerFLIP: a novel lytic peptide specifically inducing cancer cell death.

Authors:  B Pennarun; G Gaidos; O Bucur; A Tinari; C Rupasinghe; T Jin; R Dewar; K Song; M T Santos; W Malorni; D Mierke; R Khosravi-Far
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

Review 4.  The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.

Authors:  Yuanyuan Zhang; Zemin Zhang
Journal:  Cell Mol Immunol       Date:  2020-07-01       Impact factor: 11.530

5.  A multiomics comparison between endometrial cancer and serous ovarian cancer.

Authors:  Hui Zhong; Huiyu Chen; Huahong Qiu; Chen Huang; Zhihui Wu
Journal:  PeerJ       Date:  2020-01-09       Impact factor: 2.984

6.  Delivery of an immunogenic cell death-inducing copper complex to cancer stem cells using polymeric nanoparticles.

Authors:  Ginevra Passeri; Joshua Northcote-Smith; Kogularamanan Suntharalingam
Journal:  RSC Adv       Date:  2022-02-11       Impact factor: 3.361

7.  A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer.

Authors:  Huiru Dai; Minling Liu; Xueying Li; Tingwei Li; Wensheng Huang; Jiehao Liao; Yun Li; Shuo Fang
Journal:  World J Surg Oncol       Date:  2022-08-26       Impact factor: 3.253

Review 8.  MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages.

Authors:  Graziella Curtale
Journal:  Cells       Date:  2018-02-08       Impact factor: 6.600

9.  Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.

Authors:  Pooja Kaur; Alice Johnson; Joshua Northcote-Smith; Chunxin Lu; Kogularamanan Suntharalingam
Journal:  Chembiochem       Date:  2020-09-22       Impact factor: 3.164

10.  Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects.

Authors:  Adriana Petrazzuolo; Maria Perez-Lanzon; Isabelle Martins; Peng Liu; Oliver Kepp; Véronique Minard-Colin; Maria Chiara Maiuri; Guido Kroemer
Journal:  Cell Death Dis       Date:  2021-07-16       Impact factor: 8.469
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.